Catalyst Wire Dossier Catalyst Wire Dossier

Januvia/metformin fixed-dose combination

sitagliptin/metformin · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Januvia/metformin fixed-dose combination, covering 2014-09-15 to 2014-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) [Phase 4]

See pricing